Patents by Inventor Mark Dornan
Mark Dornan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12514939Abstract: Stabilized radiopharmaceutical formulations or dosage forms comprising radiolabeled conjugates of formula RC-L-TM are disclosed. Methods of making and using stabilized radiopharmaceutical formulations or dosage forms comprising the radiolabeled conjugates are also disclosed, including the preparation and stabilization of targeted radiodiagnostic and radiotherapeutic compounds comprising the radiolabeled conjugate.Type: GrantFiled: February 18, 2025Date of Patent: January 6, 2026Assignee: ALPHA-9 ONCOLOGY, INC.Inventors: Alison Fleming, Megan Bumgarner, Thomas Kostelnik, Imma Carbo-Bague, Julie Rousseau, Chengcheng Zhang, Kaveh Matinkhoo, Jutta Wanner, Mark Dornan
-
Publication number: 20250127940Abstract: Radiopharmaceutical compositions with extended shelf life are provided, including radiopharmaceutical agents that include one or aryl-halide moieties and formulated with a gentisate compound.Type: ApplicationFiled: November 1, 2024Publication date: April 24, 2025Inventors: Joe MCCANN, Mark DORNAN
-
Publication number: 20250057998Abstract: A radiopharmaceutical 177Lu-DOTATATE compound, a composition, and a kit are provided. Further provided are methods of synthesis of a 177Lu-DOTATATE compound and methods of treatment that comprise a 177Lu-DOTATATE compound.Type: ApplicationFiled: August 28, 2024Publication date: February 20, 2025Inventors: Joe McCANN, Mark DORNAN
-
Patent number: 12195451Abstract: Provided are compounds of Formula III that enhance the efficacy of viruses by increasing spread of the virus in cells, increasing the titer of virus in cells, or increasing the antigen expression from a virus, gene or trans-gene expression from a virus, or virus protein expression in cells. Other uses, compositions and methods of using same are also provided.Type: GrantFiled: March 31, 2022Date of Patent: January 14, 2025Assignee: Ottawa Hospital Research Institute and University of OttawaInventors: Jean-Simon Diallo, Christopher Noyce Boddy, Mark Dornan, Ramya Krishnan, Rozanne Arulanandam, Fabrice Le Boeuf, Jeffrey Smith, Andrew Macklin
-
Publication number: 20240360115Abstract: Provided are compounds that enhance the efficacy of viruses by increasing spread of the virus in cells, increasing the titer of virus in cells, or increasing the antigen expression from a virus, gene or trans-gene expression from a virus, or virus protein expression in cells. Other uses, compositions and methods of using same are also provided.Type: ApplicationFiled: July 4, 2024Publication date: October 31, 2024Applicants: Ottawa Hospital Research Institute, University of OttawaInventors: Jean-Simon Diallo, Christopher Noyce Boddy, Mark Dornan, Ramya Krishnan, Rozanne Arulanandam, Fabrice Le Boeuf, Jeffrey Smith, Andrew Macklin
-
Publication number: 20220220101Abstract: Provided are compounds that enhance the efficacy of viruses by increasing spread of the virus in cells, increasing the titer of virus in cells, or increasing the antigen expression from a virus, gene or trans-gene expression from a virus, or virus protein expression in cells. Other uses, compositions and methods of using same are also provided.Type: ApplicationFiled: March 31, 2022Publication date: July 14, 2022Applicants: Ottawa Hospital Research Institute, University of OttawaInventors: Jean-Simon Diallo, Christopher Noyce Boddy, Mark Dornan, Ramya Krishnan, Rozanne Arulanandam, Fabrice Le Boeuf, Jeffrey Smith, Andrew Macklin
-
Patent number: 11339146Abstract: Provided are compounds of Formula (II) that enhance the efficacy of viruses by increasing spread of the virus in cells, increasing the titer of virus in cells, or increasing the antigen expression from a virus, gene or trans-gene expression from a virus, or virus protein expression in cells. Other uses, compositions and methods of using same are also provided.Type: GrantFiled: May 18, 2020Date of Patent: May 24, 2022Assignee: Ottawa Hospital Research Institute and University of OttawaInventors: Jean-Simon Diallo, Christopher Noyce Boddy, Mark Dornan, Ramya Krishnan, Rozanne Arulanandam, Fabrice Le Boeuf, Jeffrey Smith, Andrew Macklin
-
Publication number: 20200354351Abstract: Provided are compounds that enhance the efficacy of viruses by increasing spread of the virus in cells, increasing the titer of virus in cells, or increasing the antigen expression from a virus, gene or trans-gene expression from a virus, or virus protein expression in cells. Other uses, compositions and methods of using same are also provided.Type: ApplicationFiled: May 18, 2020Publication date: November 12, 2020Applicants: Ottawa Hospital Research Institute, University of OttawaInventors: Jean-Simon Diallo, Christopher Noyce Boddy, Mark Dornan, Ramya Krishnan, Rozanne Arulanandam, Fabrice Le Boeuf, Jeffrey Smith, Andrew Macklin
-
Patent number: 10654839Abstract: Provided are compounds of Formula (II) that enhance the efficacy of viruses by increasing spread of the virus in cells, increasing the titer of virus in cells, or increasing the antigen expression from a virus, gene or trans-gene expression from a virus, or virus protein expression in cells. Other uses, compositions and methods of using same are also provided.Type: GrantFiled: January 26, 2016Date of Patent: May 19, 2020Assignees: Ottawa Hospital Research Institute, University of OttawaInventors: Jean-Simon Diallo, Christopher Noyce Boddy, Mark Dornan, Ramya Krishnan, Rozanne Arulanandam, Fabrice Le Boeuf, Jeffrey Smith, Andrew Macklin
-
Publication number: 20180305345Abstract: Provided are compounds that enhance the efficacy of viruses by increasing spread of the virus in cells, increasing the titer of virus in cells, or increasing the cytotoxicity of virus to cells. Other uses, compositions and methods of using same are also provided.Type: ApplicationFiled: January 26, 2016Publication date: October 25, 2018Applicants: Ottawa Hospital Research Institute, University of OttawaInventors: Jean-Simon Diallo, Christopher Noyce Boddy, Mark Dornan, Ramya Krishnan, Fabrice Le Boeuf, John C. Bell, Andrew Macklin, Jeffrey Smith
-
Publication number: 20180112190Abstract: Provided are compounds that enhance the efficacy of viruses by increasing spread of the virus in cells, increasing the titer of virus in cells, or increasing the antigen expression from a virus, gene or trans-gene expression from a virus, or virus protein expression in cells. Other uses, compositions and methods of using same are also provided.Type: ApplicationFiled: January 26, 2016Publication date: April 26, 2018Applicants: Ottawa Hospital Research Institute, University of OttawaInventors: Jean-Simon Diallo, Christopher Noyce Boddy, Mark Dornan, Ramya Krishnan, Rozanne Arulanandam, Fabrice Le Boeuf, Jeffrey Smith, Andrew Macklin
-
Publication number: 20100244453Abstract: A vertical wind turbine rotatable on its vertical axis in order to capture the most direct vector of the wind, the vertical wind turbine having a horizontal inlet port in communication with a vertical air shaft within which mounted vertically, a shaft having a plurality of horizontally disposed wind turbine blades, the lower end magnetically floating to reduce friction, the lower portion of the vertical wind turbine shaft in intersecting communication with one or more horizontal shafts having a venturi design so as to draw a partial vacuum or low pressure, enhancing the downward flow of the air in the vertical wind turbine, the vertical wind turbine in communication with a generator for the production of electricity, the vertical wind turbine being rotatably but stationary mounted on a stationary object or fixedly mounted on a vehicle with the inlet port of the vertical wind turbine forwardly facing.Type: ApplicationFiled: March 12, 2010Publication date: September 30, 2010Inventor: Mark Dornan
-
Patent number: 6568695Abstract: An all-terrain riding assembly comprised of a body member, including a supporting surface for feet of the user disposed between a front housing member having a rotatably mounted roller member and a rear housing member having a rotatably mounted, cylindrically-shaped roller member articulatedly mounted to the body member and including an assembly for controlling the rotational velocity of the rear roller member and thus linear velocity of the riding assembly.Type: GrantFiled: June 29, 2001Date of Patent: May 27, 2003Inventor: Mark Dornan
-
Publication number: 20030001352Abstract: There is disclosed an all-terrain riding assembly comprised of a body member, including a supporting surface for feet of the user disposed between a front housing member having a rotatably mounted roller member and a rear housing member having a rotatably mounted, cylindrically-shaped roller member articulatedly mounted to the body member and including an assembly for controlling the rotational velocity of the rear roller member and thus linear velocity of the riding assembly.Type: ApplicationFiled: June 29, 2001Publication date: January 2, 2003Inventor: Mark Dornan
-
Patent number: 6254113Abstract: These and other objects of the present invention are achieved by an all-terrain riding assembly comprised of a body member, including a supporting surface for feet of the user disposed between a front housing member having a rotatably mounted roller member and a rear housing member having a rotatably mounted, cylindrically-shaped roller member. A plane defining the supporting surface is below a plane defined by the top portions of the front and rear roller members. In a particular preferred embodiment the rear housing member is articularly mounted to the main body member.Type: GrantFiled: February 25, 1999Date of Patent: July 3, 2001Inventor: Mark Dornan
-
Patent number: D273500Type: GrantFiled: June 11, 1979Date of Patent: April 17, 1984Inventor: Mark Dornan